bearish
Viva Biotech (维亚生物) Post-IPO: SELL the Overvalued Incubator
669 Views09 May 2019 12:48
Viva Biotech's IPO was priced at the top end with a very substantial oversubscription. We have highlighted in our earlier note that Viva Biotech's...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
x